inClinico

Application

Multimodal AI platform that forecasts the probability of success of individual clinical trials and scores alternative trial designs before implementation.

Find alternatives to inClinico

TypeApplication
RoleStandalone tool
AvailabilitySold
DeploymentSaaS
Intended forEnterprise, Researcher
SecurityVendor-asserted
CertificationsISO/IEC 27001
Trains on customer dataUnknown
Zero data retentionUnknown
Data residencyCustom region
Security featuresEncryption at rest
StatusActive
Sold withinSold on its own
PricingEnterprise quote

What it does

Features 5

pharma.ai

Sources

Pricing

Official documentation · 3 Sep 2026

Demo request required for access and pricing; targeted at buy-side analysts, BD&L executives and clinical developers.

Constraints

Official documentation · 2 Oct 2026

Derived from the security facts on this page, from the same source.

Security

Official documentation · 2 Oct 2026

Company-wide Security & IT page covering client data and IP across engagements, applied to all listed products (page names none individually). ISO 27001 refers to the ISMS. Residency is client-chosen cloud servers, recorded as custom. Training, ZDR, DPA not stated.

Sold within

Official documentation · 15 Sep 2026

pharma.ai/inclinico (already cited official-docs elsewhere on this record); no packaging restriction stated.

Modalities

Official documentation · 1 Oct 2026

Page: 'customized reports with PoS and feature impacts on probabilities generated on inputs from OMICs data, drug structure, trial protocol, preclinical data, and publications, grants, and patents'.

Intended for

Self-reported · 8 Sep 2026

Named segments: "Buy-side analysts at pharma-focused funds", "BD&L executives" doing "Mergers and Acquisitions, licensing and partnerships" at pharma companies (enterprise), and "Clinical researchers" doing trial design (researcher).

Also from Insilico Medicine

Open Insilico Medicine in the directory

Something wrong here? Send a correction — quote this product id: insilico-medicine-inclinico.